VHT vs. CNCR

Last updated Jun 24, 2026

VHT (Vanguard Health Care ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds - VHT tracks the MSCI US Investable Market Health Care 25/50 Index while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. VHT charges 0.09%/yr vs 0.79%/yr for CNCR.

Performance

VHT vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanguard Health Care ETF (VHT) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

VHT

• 1D: 1.30%
• 1M: 2.66%
• YTD: -0.03%
• 6M: -0.44%
• 1Y: 19.32%
• 3Y*: 7.09%
• 5Y*: 4.60%
• 10Y*: 10.14%

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VHT vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
VHT Vanguard Health Care ETF	0.64%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

VHT vs. CNCR - Sectors Allocation Comparison

Sectors	VHT	CNCR
Healthcare	100.0%	96.6%
Financial Services	0.0%	3.3%
Industrials	0.0%	-
Technology	0.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

VHT vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VHT

VHT Risk / Return Rank: 37
VHT Sharpe Ratio Rank: 39
VHT Sortino Ratio Rank: 42
VHT Omega Ratio Rank: 36
VHT Calmar Ratio Rank: 39
VHT Martin Ratio Rank: 32

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VHT vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard Health Care ETF (VHT) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VHT	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.32	—	—
Sortino ratio: Return per unit of downside risk	2.04	—	—
Omega ratio: Gain probability vs. loss probability	1.23	—	—
Calmar ratio: Return relative to maximum drawdown	1.87	—	—
Martin ratio: Return relative to average drawdown	4.59	—	—

Drawdowns

VHT vs. CNCR - Drawdown Comparison

The maximum VHT drawdown since its inception was -39.12%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for VHT and CNCR.

Drawdown Indicators

	VHT	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-39.12%	0.00%	-39.12%
Max Drawdown (1Y) Largest decline over 1 year	-10.40%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-16.91%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-17.71%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-28.85%	—	—
Current Drawdown Current decline from peak	-3.20%	0.00%	-3.20%
Average Drawdown Average peak-to-trough decline	-5.98%	0.00%	-5.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.22%	—	—

Volatility

Volatility by Period

	VHT	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.02%	—	—
Volatility (6M) Calculated over the trailing 6-month period	10.49%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	14.72%	0.00%	+14.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.03%	0.00%	+15.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.95%	0.00%	+16.95%

VHT vs. CNCR - Expense Ratio Comparison

VHT has a 0.09% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

VHT vs. CNCR - Dividend Comparison

VHT's dividend yield for the trailing twelve months is around 1.64%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VHT Vanguard Health Care ETF	1.64%	1.61%	1.53%	1.36%	1.33%	1.14%	1.21%	1.89%	1.38%	1.31%	1.45%	1.22%

Frequently Asked Questions

Which ETF is better, VHT or CNCR?

On fees, VHT is cheaper at 0.09% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, VHT or CNCR?

VHT is cheaper with a 0.09% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, VHT or CNCR?

VHT has the higher dividend yield at 1.64%, compared with 0.00% for CNCR.

What is the main difference between VHT and CNCR?

VHT tracks MSCI US Investable Market Health Care 25/50 Index, while CNCR tracks Loncar Cancer Immunotherapy Index. They also come from different issuers: Vanguard and Exchange Traded Concepts. Their fees differ too: 0.09% for VHT and 0.79% for CNCR.